Литература
1. Blindt R., Hoffmeister K. M., Bienert H. et al. Development of a new biodegradable intravascular polymer stent with simultaneous incorporation of bioactive substances // Int. J. Artif. Organs. - 1999. - Vol. 22. - P. 843-853.
2. Eury K. R. Multi-layered biodegradable stent and method for its manufacture. European Patent 604022 A1.
3. Fischman D., Leon M., Baim D. et al. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. The STRESS Trial // N. Engl. J. Med. - 1994. - Vol. 331. - P. 496-501.
4. Hastings G. W. (ed). Cardiovascular biomaterials. - London: Springer-Verlag.,1992.
5. Heublein B., Rohde R., Kaese V. et al. Biocorrosion of magnesium alloys: A new principle in cardiovascular implant technology? // Heart. - 2003. - Vol. 89. - P. 651-656.
6. Hietala E. M., Salminen U. S., Stahls A. et al. Biodegradation of the copolymeric polylactide stent.: Long-term follow-up in a rabbit aorta model // J. Vasc. Res. -2001. - Vol. 38. - P. 361-369.
7. Konig A., Schiele T. M., Rieber J. et al. Influence of stent design and deployment technique on neointima formation and vascular remodeling // Z. Kardiol. - 2002. - Bd. 91 (Suppl. 3). - S. 98-102.
8. Lincoff A. M., Furst J. G., Ellis S. G. et al. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model // J. Amer. Coll. Cardiol. - 1997. - Vol. 29. - P. 808-816.
9. Murphy J. G., Schwartz R. S., Huber K. C., Holmes D. R. Jr. Polymeric stents: Modern alchemy or the future? // J. Invas. Cardiol. - 1991. - Vol. 3. - P. 144-148.
10. Peuster M., Wohlsein P., Brugmann M. et al. A novel approach to temporary stenting: Degradable cardiovascular stents produced from corrodible metal- results 6-18 months after implantation into New Zealand white rabbits // Heart. - 2001. - Vol. 86. - P. 563-569.
11. Savage P. M., Fischman D. L., Schatz R. A. et al. Long-term angiographic and clinical outcome after implantation of a balloon-expandable stent in the native coronary circulation // J. Amer. Coll. Cardiol. - 1994. - Vol. 24. - P. 1207-1212.
12. Serruys P. W., de Jaegere P., Kiemeneij F. et al. for the BENESTENT Study Group. A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease // N. Engl. J. Med. - 1994. - Vol. 331. - P. 489-495.
13. Stack R. E., Califf R. M., Phillips H. R. et al. Interventional cardiac catheterization at Duke Medical Center // Amer. J. Cardiol. - 1988. - Vol. 62 (Suppl. F). - P. 3F-24F.
14. Tamai H., Igaki K., Kyo E. et al. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans // Circulation. - 2000. - Vol. 102. - P. 399-404.
15. Tamai H., Igaki K., Tsuji T. et al. A biodegradable poly-l-lactic acid coronary stent in porcine coronary artery // J. Interv. Cardiol. - 1999. - Vol. 12. - P. 443-450.
16. Tsuji T., Tamai H., Igaki K. et al. Biodegradable polymeric stents // Curr. Interv. Cardiol. Rep. - 2001. - Vol. 3. - P. 10-17.
17. Tsuji T., Tamai H., Igaki K. et al. Biodegradable stents as a platform to drug loading // Int. J. Cardiovasc. Intervent. - 2003. - Vol. 5. - P. 13-16.
18. Tsuji T., Tamai H., Igaki K. et al. One year followup biodegradable self-expanding stent implantation in humans // J. Amer. Coll. Cardiol. - 2001. - Vol. 37(Abstr). - P. A47.
19. Van der Giessen W., Lincoff M., Schwartz R. et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries // Circulation. - 1996. - Vol. 94. - P. 1690-1697.
20. Virmani R., Farb A., Guagliumi G., Kolodgie F. D. Drug-eluting stents. - P. Caution and concerns for long-term outcome // Coron. Artery Dis. - 2004. - Vol. 15. - P. 313-318.
21. Vogt F., Stein A., Rettemeier G. et al. Long-term assessment of a novel biodegradable paclitaxel-eluting coronary polylactide stent // Eur. Heart. J. -2004. - Vol. 25. - P. 1330-1340.
22. Waksman R. Biodegradable stents: they do their job and disappear // J. Invas. Cardiol. - 2006. - Vol. 18, № 2. - P. 70-74.
23. Yamawaki T., Shimokawa H., Kozai T. et al. Intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo // J. Amer. Coll. Cardiol. - 1998. - Vol. 32. - P. 780-786.
24. Ye Y. W., Landau C., Meidell R. S. et al. Improved bioresorbable microporous intravascular stents for gene therapy // ASAIO J. - 1996. - Vol. 42. - P. M823-827.
25. Ye Y. W., Landau C., Willard J. E. et al. Bioresorbable microporous stents deliver recombinant adenovirus gene transfer vectors to the arterial wall // Ann. Biomed. Eng. - 1998. - Vol. 26. - P. 398-408.
